Randomized phase II study of WT1 peptide vaccine plus gemcitabine for advanced pancreatic ductal adenocarcinoma (PDAC): Clinical efficacy and immune response
Abstract only
Saved in:
Published in | Journal of Clinical Oncology Vol. 34; no. 15_suppl; p. 3085 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English Japanese |
Published |
American Society of Clinical Oncology (ASCO)
20.05.2016
|
Online Access | Get full text |
ISSN | 0732-183X 1527-7755 |
DOI | 10.1200/jco.2016.34.15_suppl.3085 |
Cover
Summary: | Abstract only |
---|---|
ISSN: | 0732-183X 1527-7755 |
DOI: | 10.1200/jco.2016.34.15_suppl.3085 |